[HTML][HTML] 2018 Korean Liver Cancer Association–National Cancer Center Korea practice guidelines for the management of hepatocellular carcinoma

Korean Liver Cancer Association - Korean Journal of Radiology, 2019 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …

2018 Korean Liver Cancer Association-National Cancer Center Korea practice guidelines for the management of hepatocellular carcinoma

JW Park, JS Lee, KS Suh, JW Chung, J Seong… - Gut and …, 2019 - scholarworks.bwise.kr
Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …

Prognostic and predictive factors in patients with brain metastases from solid tumors: a review of published nomograms

C Nieder, MP Mehta, H Geinitz, AL Grosu - Critical reviews in oncology …, 2018 - Elsevier
Objective To review published nomograms that predict endpoints such as overall survival
(OS) or risk of intracranial relapse in patients with brain metastases from solid tumors …

2018 Korean Liver Cancer Association–National Cancer Center Korea practice guidelines for the management of hepatocellular carcinoma

Korean Liver Cancer Association … - Korean Journal of …, 2019 - synapse.koreamed.org
Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …

Radiation therapy in the era of immune treatment for hepatocellular carcinoma

L Chen, R Zhang, Z Lin, Q Tan, Z Huang… - Frontiers in …, 2023 - frontiersin.org
Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment in recent years
and provide new opportunities to treat hepatocellular carcinoma (HCC). To date, several …

[HTML][HTML] Treatment strategies for hepatocellular carcinoma with extrahepatic metastasis

HY Long, TY Huang, XY Xie, JT Long… - World Journal of Clinical …, 2021 - ncbi.nlm.nih.gov
Extrahepatic metastasis (EHM) of hepatocellular carcinoma (HCC) has increasingly been
seen due to improved survival with effective management of intrahepatic lesions. The …

[HTML][HTML] Brain metastases from hepatocellular carcinoma: recent advances and future avenues

S Wang, A Wang, J Lin, Y Xie, L Wu, H Huang, J Bian… - Oncotarget, 2017 - ncbi.nlm.nih.gov
The incidence of brain metastases from hepatocellular carcinoma (BMHCC) is becoming
more frequent than that of the past as a result of prolonged survival of patients with HCC …

Computer tomography radiomics-based nomogram in the survival prediction for brain metastases from non-small cell lung cancer underwent whole brain radiotherapy

J Zhang, J Jin, Y Ai, K Zhu, C Xiao, C Xie… - Frontiers in Oncology, 2021 - frontiersin.org
Prognostic parameters and models were believed to be helpful in improving the treatment
outcome for patients with brain metastasis (BM). The purpose of this study was to investigate …

[HTML][HTML] Connecting the dots: the cerebral lymphatic system as a bridge between the central nervous system and peripheral system in health and disease

H Zhao, M Sun, Y Zhang, W Kong, L Fan… - Aging and …, 2024 - ncbi.nlm.nih.gov
As a recently discovered waste removal system in the brain, cerebral lymphatic system is
thought to play an important role in regulating the homeostasis of the central nervous …

[HTML][HTML] A nomogram to predict prognosis of patients with unresected hepatocellular carcinoma undergoing radiotherapy: a population-based study

L Zhang, L Yan, H Niu, J Ma, BY Yuan, YH Chen… - Journal of …, 2019 - ncbi.nlm.nih.gov
Background: Radiotherapy is a primary treatment strategy for patients with unresectable
hepatocellular carcinoma (HCC); however, the prognostic factors among HCC patients who …